Search
for

    Sort by

    Research 631–660 of 1000+

    1. Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression Frontiers in Pharmacology · 2022 · 12 citations
    2. The good, the bad, and the ugly facets of insulin resistance Medical Journal Armed Forces India · 2020 · 11 citations
    3. The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration Hormones · 2013 · 11 citations
    4. Clinical Response to Combined Therapy of Cyclosporine and Prednisone 2013 · 10 citations
    5. Alcohol and Prostate Cancer: Time to Draw Conclusions Biomolecules · 2022 · 9 citations
    6. Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study Journal of Human Reproductive Sciences · 2024 · 8 citations
    7. Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells International Journal of Molecular Sciences · 2022 · 8 citations
    8. CD99 Is Strongly Expressed in Basal Cells of the Normal Adult Epidermis and Some Subpopulations of Appendages: Comparison with Developing Fetal Skin Journal of pathology and translational medicine · 2016 · 8 citations
    9. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses Cancer Research Communications · 2024 · 7 citations
    10. Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation BMC Cancer · 2011 · 7 citations
    11. A novel 22-bp InDel within <i>FGF7</i> gene is significantly associated with growth traits in goat Animal Biotechnology · 2023 · 6 citations
    12. Sox13 is a novel early marker for hair follicle development Biochemical and Biophysical Research Communications · 2019 · 6 citations
    13. Heterogeneity in the genetic alterations and in the clinical presentation of acrodermatitis enteropathic: Case report and review of the literature International journal of immunopathology and pharmacology · 2015 · 6 citations
    14. The exaptation of endocrine pharmacology Indian Journal of Endocrinology and Metabolism · 2012 · 6 citations
    15. The role of <i>Atg5</i> gene in tumorigenesis under autophagy deficiency conditions The Kaohsiung Journal of Medical Sciences · 2024 · 4 citations
    16. Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors Frontiers in Oncology · 2023 · 4 citations
    17. Special collection on inward rectifying K<sup>+</sup> channels American journal of physiology. Cell physiology · 2023 · 3 citations
    18. Zinc deficiency is associated with gynecologic cancer recurrence Frontiers in oncology · 2022 · 3 citations
    19. Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism South East European Journal of Immunology · 2023 · 2 citations
    20. Hair cortisol in polycystic ovary syndrome Scientific reports · 2022 · 2 citations
    21. New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases International Journal of Molecular Sciences · 2025 · 1 citations
    22. Zinc‐Coordinated Trienzyme Nanogel Cascade Therapy for Accelerated Post‐Pancreatectomy Cutaneous Wound Healing Advanced Materials · 2025 · 1 citations
    23. Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome K<sub>ATP</sub>Channel Mutations in Intact Cells 2023 · 1 citations
    24. ODAC Chairs Reveal Challenges, High Drama in a Decade of Service Oncology Times · 2013 · 1 citations
    25. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    26. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    27. XIAP Stabilizes DDRGK1 to Promote ER‐Phagy and Protects Against Noise‐Induced Hearing Loss Advanced Science · 2026
    28. Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies Biomedicines · 2025
    29. Morphometric prediction of mesenchymal stromal cell-like immunosuppressive capacity of human hair follicle dermal sheath cup cells: an implication for regenerative medicine in hair loss diseases Stem Cell Research & Therapy · 2025
    30. Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management Applied Research · 2025